Singapore markets closed

Globus Medical, Inc. (GMED)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
64.46+0.51 (+0.80%)
At close: 03:59PM EDT
64.40 -0.06 (-0.09%)
After hours: 04:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 8.64B
Enterprise value 8.73B
Trailing P/E 118.43
Forward P/E 23.26
PEG ratio (5-yr expected) 2.11
Price/sales (ttm)4.14
Price/book (mrq)2.20
Enterprise value/revenue 4.60
Enterprise value/EBITDA 24.55

Trading information

Stock price history

Beta (5Y monthly) 1.11
52-week change 313.87%
S&P500 52-week change 326.36%
52-week high 365.74
52-week low 343.39
50-day moving average 353.68
200-day moving average 352.18

Share statistics

Avg vol (3-month) 31.17M
Avg vol (10-day) 31.93M
Shares outstanding 5112.63M
Implied shares outstanding 6135.06M
Float 8111.66M
% held by insiders 10.77%
% held by institutions 1102.84%
Shares short (30 Apr 2024) 48.99M
Short ratio (30 Apr 2024) 410.16
Short % of float (30 Apr 2024) 48.94%
Short % of shares outstanding (30 Apr 2024) 46.66%
Shares short (prior month 28 Mar 2024) 47.76M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 3.51%
Operating margin (ttm)13.71%

Management effectiveness

Return on assets (ttm)5.27%
Return on equity (ttm)2.28%

Income statement

Revenue (ttm)1.9B
Revenue per share (ttm)15.58
Quarterly revenue growth (yoy)119.30%
Gross profit (ttm)N/A
EBITDA 480.82M
Net income avi to common (ttm)66.63M
Diluted EPS (ttm)0.54
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)434.47M
Total cash per share (mrq)3.22
Total debt (mrq)526.3M
Total debt/equity (mrq)13.42%
Current ratio (mrq)2.33
Book value per share (mrq)29.04

Cash flow statement

Operating cash flow (ttm)242.57M
Levered free cash flow (ttm)-307.72M